Canada markets closed

Lumiera Health Inc. (NHP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 02:41PM EST
Full screen
Previous Close0.0150
Open0.0150
Bid0.0150 x 0
Ask0.0200 x 0
Day's Range0.0150 - 0.0150
52 Week Range0.0150 - 0.1200
Volume175,000
Avg. Volume313,303
Market Cap2.549M
Beta (5Y Monthly)3.35
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

    VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

  • CNW Group

    Lumiera ends fiscal year strong with sales in November 2021 up 59% compared to November 2020

    Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to provide an update to announce that the new corporate strategy and plans that were put in place Q1-Q3 2021 have been successful. Lumiera's fiscal Q4 was a record quarter with sales +30% vs Q4 2020, highlighted by November which was a record sale month, +59.3% over November 2020.

  • CNW Group

    Lumiera Health Appoints Louis Doyle to Board of Directors

    Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to announce that Louis Doyle has been appointed to the Board of Directors of the Company following the resignation of Nathalie Nasseri as a director of the Company.